One of the only facts we know about Parkinson’s disease (PD) and medical marijuana is that more research is needed to understand the utility of marijuana or cannabis to treat Parkinson’s symptoms.
Parkinson's Today Blog
Does Parkinson’s disease (PD) only affect movement? Can doctors predict its progression? Can stem cells cure Parkinson’s? In this Neuro Talk, our Chief Scientific Officer, James Beck, PhD, debunks seven common myths about Parkinson's disease.
Over the next three years the Parkinson’s Foundation will invest more than $50 million to Parkinson’s disease (PD) research and clinical care. At the heart of our research initiatives are scientists and researchers who have received Foundation awards to improve our understanding of Parkinson’s, which will ultimately lead us to a cure.
Men are more likely to develop Parkinson’s disease (PD) than women, and the onset of PD in men happens at a younger age. However, women with PD have a higher mortality rate, and once they have Parkinson’s, progression is faster. Research suggests that women get the disease at later in life when compared to men, at least in part, due to the natural protection estrogen provides.
New Year’s resolutions are an opportunity for reflection, change and improvement. Take the time to plan for the year ahead with a fresh, clear outlook. These attainable goals for 2020 can give you inspiration while highlighting exactly how you can get started.
The past two weeks have offered more definitive information on Nilotinib (Tasigna), a drug already approved for treatment of leukemia, as a potential treatment for Parkinson’s disease (PD) symptoms. On December 16, JAMA Neurology published the results of a Phase II safety trial ― a study that tests the effectiveness of a drug or treatment in a larger group of people. Study findings revealed that Nilotinib had more adverse events than the placebo (a pill not containing an active drug) but was reasonably safe.
Donna Hood, PhD, Chair of Division of Nursing and Tara Haskins, PhD, Associate Professor of Nursing at Louisiana Tech University are Parkinson’s Foundation Nurse Faculty Award recipients who received grant funding to launch The Parkinson Resource Center at Louisiana Tech University.
Parkinson’s Foundation Research Advocates were the first people with Parkinson’s disease (PD) to help guide the grant review process for the Department of Defense (DoD) Parkinson’s Research Program. The program supports research to understand, prevent, diagnose and treat Parkinson’s disease.
Senator Johnny Isakson (R-GA), Senior United States Senator from Georgia will retire from his 45 years in public office on December 31, 2019. The Parkinson’s Foundation is grateful for his longtime commitment to our community, championing Parkinson’s research toward a cure.
Senator Isakson announced his own Parkinson’s diagnosis in 2015, along with his commitment to fight the disease.